Close Menu

NEW YORK – Telegenomics firm Genome Medical said Wednesday that it has raised $14 million in an extended Series B financing round, adding to the $23 million it raised in the Series B financing last year.

The San Francisco-headquartered company plans to use the funds to improve patient engagement and navigation within its Genome Care Delivery technology platform, so that more patients in the US have access to genomic medicine for cancer, reproductive health, and pharmacogenetics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.